You are required to be logged in to access the full website
Click here if you have forgotten your username or password
3 August 2026 - CTC intelligence company CelLBxHealth plc (AIM: CLBX) on Monday announced a peer-reviewed study demonstrating the use of its Parsortix platform to detect antibody-drug conjugate (ADC)-relevant targets on circulating tumour cells (CTCs...
3 August 2026 - Swedish pharmaceutical company Immedica, backed by investment firms KKR & Co Inc (NYSE:KKR) and Impilo, announced on Monday that Qatar's Ministry of Public Health has approved Zepzelca (lurbinectedin) in combination with atez...
3 August 2026 - Coiled Therapeutics plc (AIM: COIL) (OTCQB: COTXF), a clinical-stage precision oncology company, announced on Monday that it has dosed the first patient in the US with an optimised lipid-based oral formulation of its Phase I cancer th...
3 August 2026 - Ridgetech Inc (Nasdaq:RDGT), a wholesale distributor of pharmaceutical and other healthcare products in China, on Friday reported its financial results for the fiscal year ended 31 March 2026.Full-year revenue was USD132.16m, up 10.2%...
3 August 2026 - CREATE Medicines Inc, a clinical-stage biotechnology company, announced on Friday that it has entered into a strategic research collaboration with Australia's Monash University and its Monash Institute of Pharmaceutical Sciences ...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe